Article
HCV genotypes, characterization of mutations conferring drug resistance to protease inhibitors, and risk factors among blood donors in São Paulo, Brazil.
PloS one - 1 Jan 2014
Nishiya Anna S, de Almeida-Neto Cesar, Ferreira Suzete C, Alencar Cecília S, Di-Lorenzo-Oliveira Claudia, Levi José E, Salles Nanci A, Mendrone Alfredo, Sabino Ester C
Abstract excerpt
BACKGROUND: Hepatitis C virus (HCV) infection is a global health problem estimated to affect almost 200 million people worldwide. The aim of this study is to analyze the subtypes and existence of variants resistant to protease inhibitors and their association with potential HCV risk factors among blood donors in Brazil. METHODS: Repeat anti-HCV reactive blood donors are systematically asked to return for retest,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
